ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

CAN-DIAL Test Generates 16,000 Calls for Cancer Information

December 13, 1974

Sandra Swain Elected ASCO President for 2012

December 10, 2010

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

DeMets Receives Lectureship On Epidemiology From NIH.

May 4, 2001